Life exists in motion. CellChorus® is a high-throughput platform for evaluating how individual cells move, behave and interact. The company applies visual AI to evaluate Time-lapse Imaging Microscopy in Nanowell Grids (TIMING™) videos and characterize cell behavior such as movement, activation, killing and survival.
Location: United States
Employees: 1-10
Total raised: $400K
Founded date: 2020
Investors 7
| Date | Name | Website |
| - | BioTools I... | biotoolsin... |
| 15.09.2021 | Plug and P... | plugandpla... |
| 16.08.2021 | Y Combinat... | ycombinato... |
| - | Rose Ventu... | roseventur... |
| 19.05.2022 | MBC BioLab... | mbcbiolabs... |
| 09.10.2022 | Breakout V... | breakout.v... |
| - | Endless Fr... | endlessfro... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 22.05.2026 | Seed | $400K | - |
Mentions in press and media 10
| Date | Title | Description |
| 22.05.2026 | Houston's Innovation Surge: Pharma, AI, Geothermal, and Rapid E-commerce Reshape the City | Houston’s economy propels forward. Major investments flood diverse sectors. The city solidifies its role as an innovation hub. Pharmaceutical giant Bristol Myers Squibb considers a $1 billion manufacturing campus. Eli Lilly already committe... |
| 22.05.2026 | Persona AI teams with Under Armour to protect next-gen robots | Houston-based Persona AI has cemented a partnership with sportswear manufacturer Under Armour to provide materials to protect future robots operating in dangerous conditions. Through the partnership, Persona AI and Under Armour will launch ... |
| 19.05.2026 | Pharma giant considers Houston for $1B manufacturing campus | Another pharmaceutical giant is considering Houston’s Generation Park for a manufacturing hub. According to a recent filing with the Texas Jobs, Energy, Technology and Innovation (JETI) program, Bristol Myers Squibb Co. is considering the n... |
| 18.05.2026 | Houston health tech co. lands NIH grant for AI cancer prediction tool | Houston-based CellChorus and Stanford Medicine were recently awarded a Phase I Small Business Innovation Research grant for the company's AI platform to test how certain cancer patients will respond to therapies. The funding comes from the ... |
| 15.05.2026 | Houston leads the way in innovative brain research and more news to know | Editor's note: The top Houston innovation news for the first half of May includes an initial round of brain research grants from Rice and FDA approval for clinical trial of a Houston startup's brain implant. Below are the five most-read Inn... |
| 06.09.2023 | TechCrunch Disrupt 2023 Startup Battlefield 200: Health tech and sustainability | You’re just a couple weeks away from meeting the Startup Battlefield 200 companies in person at TechCrunch Disrupt 2023! We’re incredibly proud of — and impressed by — this year’s hand-picked cohort. To avoid utter overwhelm, we’re announci... |
| 12.10.2022 | CellChorus adopts Scispot’s tech stack to scale their life science startup | Biotech Operating System “CellChorus works with some of the most innovative leaders in the industry. Scispot gives us a competitive advantage as a techbio startup,” said Daniel Meyer, CEO of CellChorus. KITCHENER, Ontario (PRWEB) October 12... |
| 10.12.2021 | StartUPDATES: New developments for healthcare startups | Healthmine recently shared an article written by AIS Health with support from EVP of Consulting & Professional Services, Melissa Smith. The article discusses paused measures that may have inflated 2022 Star Ratings, but also offers impo... |
| 01.09.2021 | Here are all the companies from Day 2 of Y Combinator’s Summer 2021 Demo Day | Welcome back to TechCrunch’s continuing coverage of Y Combinator’s Summer 2021 Demo Day! This is Day Two. If you haven’t caught up yet on what happened during the first day, you can read our recap of all the presenting companies here, our f... |
| - | StartUPDATES: New developments for healthcare startups | Healthmine recently shared an article written by AIS Health with support from EVP of Consulting & Professional Services, Melissa Smith. The article discusses paused measures that may have inflated 2022 Star Ratings, but also offers impo... |